Publications
64
Citations
2,050
Est. group size
~8
Recurring co-author estimate
Active years
17
Publishing since 2010
Andrew J. Gunderson studies how the immune system interacts with tumors, with particular focus on T cell responses in cancers such as pancreatic, rectal, and skin (squamous) tumors, as well as glioblastoma. Much of the work examines how signaling molecules like TGFβ and enzymes like Bruton Tyrosine Kinase suppress or shape anti-tumor immune activity, aiming to inform new immunotherapy approaches. This research combines laboratory tumor models with data from clinical trials testing drugs that block these immune-suppressing pathways.
Publication output has grown over the last decade, rising from just a couple of papers per year around 2017-2018 to a notable peak of 13 in 2023, with continued higher output through 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Plasma cell and cancer stem cell crosstalk in glioblastoma
Cancer Cell · 2025
- TGFβ limits proximal CD8+ TCR signaling via PTPN22 following strong and moderate agonism
The Journal of Immunology · 2025
- LAGging behind no more: PD-1 has a new immunotherapy partner
Immunity · 2024
- Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help
Scientific Reports · 2023
- Supplementary Table 1 and Supplementary Figures 1 through 7 from Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-Ras<sup>G12V</sup>–Induced Squamous Tumors
2023
- Data from Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-Ras<sup>G12V</sup>–Induced Squamous Tumors
2023
- Supplementary Methods, Figure Legends from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
2023
- Supplementary Figures S1 - S6 from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
2023
- Supplementary Methods, Figure Legends from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
2023
- Supplementary Figures S1 - S6 from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
2023
- Supplementary Table 1 and Supplementary Figures 1 through 7 from Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-Ras<sup>G12V</sup>–Induced Squamous Tumors
2023
- Data from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
2023
- Data from Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
2023
- Data from Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-Ras<sup>G12V</sup>–Induced Squamous Tumors
2023
- Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers
Cancer Cell · 2022
- Cancer Research×6
- Regular and Young Investigator Award Abstracts×4
- Cancer Cell×3
- PLoS ONE×2
- Cancers×2
- Joseph Azar
Medicine · The Ohio State University
- Vijaya Bharti
Medicine · The Ohio State University
- Shreya Kumar
Medicine · Purdue University West Lafayette
- Scott A. Hammond
Medicine · The Ohio State University
- Richard C. Wu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile